Acuta Capital Partners, LLC Homology Medicines, Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 15, 2018
SELL
$16.49 - $21.55 $1.3 Million - $1.7 Million
-79,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$18.66 - $18.7 $1.47 Million - $1.48 Million
79,000 New
79,000 $1.48 Million

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email